STUDY GUIDE 2025/2026 QUESTIONS WITH VERIFIED
CORRECT SOLUTIONS || 100% GUARANTEED PASS
<BRAND NEW VERSION>
Neuropharmacology - ANSWER Studies how drugs influence the nervous system
to modify behavior, cognition, and physiological function.
Molecular Neuropharmacology - ANSWER Interactions at receptor and signaling
level.
Behavioral Neuropharmacology - ANSWER How drugs affect behavior and
mental states.
Acetylcholine (ACh) - ANSWER Major neurotransmitter involved in memory,
attention, and autonomic regulation.
Dopamine (DA) - ANSWER Major neurotransmitter involved in reward,
motivation, and motor control.
Serotonin (5-HT) - ANSWER Major neurotransmitter involved in mood, sleep,
pain, and gastrointestinal function.
Norepinephrine (NE) - ANSWER Major neurotransmitter involved in arousal,
stress, attention, and blood pressure.
GABA (γ-aminobutyric acid) - ANSWER Major neurotransmitter providing
inhibitory tone and seizure control.
, Glutamate - ANSWER Major neurotransmitter involved in learning, memory, and
excitotoxicity.
Cholinergic Drugs - ANSWER Drugs that affect acetylcholine receptors, including
agonists, anticholinesterases, and anticholinergics.
Dopaminergic Agents - ANSWER Drugs that target dopamine pathways,
including agonists, reuptake inhibitors, and antagonists.
Serotonergic Agents - ANSWER Drugs that affect serotonin levels, including
SSRIs, SNRIs, and various agonists and antagonists.
GABAergic Agents - ANSWER Drugs that enhance GABA activity, including
GABA-A agonists and GABA analogs.
Glutamatergic Modulators - ANSWER Drugs that modulate glutamate activity,
including NMDA antagonists and AMPA modulators.
Parkinson's Disease - ANSWER Characterized by decreased dopamine in the
substantia nigra, treated with levodopa and dopamine agonists.
Alzheimer's Disease - ANSWER Characterized by decreased acetylcholine and
amyloid & tau accumulation, treated with cholinesterase inhibitors.
Epilepsy - ANSWER Characterized by excess neuronal firing, treated with GABA
enhancers and sodium channel blockers.
Depression - ANSWER Characterized by decreased monoamines (5-HT, NE, DA),
treated with SSRIs and SNRIs.
Anxiety - ANSWER Characterized by a hyperactive limbic system, treated with
SSRIs and benzodiazepines.
Schizophrenia - ANSWER Characterized by increased dopamine in the
mesolimbic pathway, treated with D2 antagonists.
, Migraine - ANSWER Characterized by vascular and serotonin dysregulation,
treated with triptans and beta blockers.
Multiple Sclerosis - ANSWER Characterized by autoimmune demyelination,
treated with immunomodulators and steroids.
Antipsychotics - ANSWER Watch for extrapyramidal symptoms, QT
prolongation, and increased prolactin.
SSRIs/SNRIs - ANSWER Watch for sexual dysfunction and serotonin syndrome.
MAOIs - ANSWER Watch for hypertensive crisis when consuming tyramine
foods.
Anticholinergics - ANSWER Watch for dry mouth, urinary retention, and
confusion, especially in the elderly.
Levodopa - ANSWER Watch for dyskinesias and hallucinations.
Benzodiazepines - ANSWER Watch for dependence, withdrawal, and sedation.
BALSA - ANSWER Mnemonic for Parkinson's: Bromocriptine, Amantadine,
Levodopa, Selegiline, Antimuscarinics
BAD TRIP - ANSWER Mnemonic for serotonin syndrome: Benzos, Agitation,
Diaphoresis, Tachycardia, Reflexes ↑, Incoordination, Pyrexia
Direct Muscarinic Agonists - ANSWER Drugs that bind directly to muscarinic
receptors and activate them.
Pilocarpine - ANSWER Used for glaucoma and xerostomia (dry mouth).
Bethanechol - ANSWER Used for urinary retention and postoperative ileus.
, Carbachol - ANSWER Used for glaucoma (rarely used).
Methacholine - ANSWER Used as a diagnostic test for bronchial hyperreactivity.
Cevimeline - ANSWER Used for xerostomia in Sjögren's syndrome.
Muscarine - ANSWER Found in some poisonous mushrooms (not used clinically).
Indirect Muscarinic Agonists - ANSWER Cholinesterase Inhibitors that inhibit
acetylcholinesterase, increasing endogenous acetylcholine levels.
Neostigmine - ANSWER Used for myasthenia gravis and postoperative ileus.
Physostigmine - ANSWER Used for anticholinergic toxicity (e.g., atropine
overdose).
Donepezil - ANSWER Used for Alzheimer's disease.
Rivastigmine - ANSWER Used for Alzheimer's and Parkinson's dementia.
Pyridostigmine - ANSWER Used for myasthenia gravis.
Edrophonium - ANSWER Historically used in diagnosis of myasthenia gravis.
Key Muscarinic Effects - ANSWER SLUDGE-M: Salivation, Lacrimation,
Urination, Diarrhea, Gastrointestinal motility, Emesis, Miosis (pupil constriction),
bradycardia, bronchoconstriction.
Anticholinergic Drugs - ANSWER Medications that block the action of
acetylcholine (ACh) at muscarinic receptors.
Mechanism of Action of Anticholinergics - ANSWER Most are muscarinic
antagonists that competitively inhibit ACh at muscarinic receptors (M1-M5).
Benztropine - ANSWER Used for Parkinson's disease and drug-induced EPS.